Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.
AffiliationDepartment of Histopathology, St Vincent's University Hospital, Dublin 4,, Ireland. firstname.lastname@example.org
MetadataShow full item record
CitationJ Clin Pathol. 2009 Dec;62(12):1136-40.
JournalJournal of clinical pathology
AbstractAIMS: Needle core biopsy (NCB) is a widely-used technique for non-operative evaluation of screen-detected breast lesions. Although most NCBs are B2 (benign) or B5 (malignant), some fall into the B3 category of "uncertain malignant potential". This study aims to categorise the lesions prompting a B3 NCB in the Merrion Breast Screening Unit, and establish the incidence of malignancy on subsequent excision biopsy. METHODS: Patients attending the Merrion Breast Screening Unit in Dublin between 2000 and 2008 who had a B3 NCB were identified. The NCB pathology reports were reviewed and the diagnosis correlated with excision histology; the latter was classified as benign, atypical or malignant. Lesion-specific positive predictive values (PPVs) for malignancy were derived. RESULTS: 141 patients with a B3 NCB were identified. The most frequent lesions on NCB were radial scar (RS; n = 57), atypical intraductal epithelial proliferation (AIDEP; n = 25) and papillary lesion (n = 24). The final diagnosis was malignant in 22 patients (16%), atypical in 40 (28%) and benign in 79 (56%). Two of the patients with a malignant diagnosis had invasive carcinoma. The lesion-specific PPVs were: lobular neoplasia 50%, AIDEP 32%, columnar cell lesion with atypia 12.5%, RS 12.3%, papillary lesion 8.3%, suspected phyllodes tumour 7.7%, and spindle cell lesion 0%. Atypia on RS NCB predicted an atypical or malignant excision diagnosis, but atypia on papillary lesion NCB did not. CONCLUSIONS: One-sixth of B3 NCBs in this series proved to be malignant on excision. The PPV for malignancy varied according to lesion type.
- Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
- Authors: El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO
- Issue date: 2008 Dec
- Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
- Authors: Dillon MF, McDermott EW, Hill AD, O'Doherty A, O'Higgins N, Quinn CM
- Issue date: 2007 Feb
- Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
- Authors: Carder PJ, Garvican J, Haigh I, Liston JC
- Issue date: 2005 Mar
- Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.
- Authors: Rakha EA, Ho BC, Naik V, Sen S, Hamilton LJ, Hodi Z, Ellis IO, Lee AH
- Issue date: 2011 Mar
- Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
- Authors: Richter-Ehrenstein C, Maak K, Röger S, Ehrenstein T
- Issue date: 2018 Aug 16